From Biomarkers to Treatment: The New Need-to-Know in Early Breast Cancer

Download All
Learn from expert faculty as they discuss emerging biomarkers and other recent data changing practice in early breast cancer, including a downloadable slideset from a satellite symposium, an on-demand webcast, and expert commentary.
Heather McArthur, MD, MPH
Program Director

ClinicalThought

Management of early-stage breast cancer is rapidly evolving with perioperative options now including abemaciclib, olaparib, and pembrolizumab. In this commentary, Heather McArthur, MD, MPH, shares key takeaways on the latest developments.

Heather McArthur, MD, MPH
Program Director
Released: August 4, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Lilly
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings